News
GlaxoSmithKline's Arzerra gets positive recommendation for conditional EU approval Yahoo/AP
View ArticleGenmab says rivals appeal U.S. ruling in patent suit
Genmab says rivals appeal U.S. ruling in patent suit Reuters
View ArticleGlaxoSmithKline and Genmab A/S submit NDA to MHLW for Arzerra
GlaxoSmithKline and Genmab A/S submit NDA to MHLW for Arzerra Yahoo/Fly on the Wall
View ArticleBreakthrough status for GSK and Genmab leukemia drug
Breakthrough status for GSK and Genmab leukemia drug Pharma Times, UK
View ArticleIs the Tide About to Turn in the Fight Against Chronic Lymphocytic Leukemia?
Is the Tide About to Turn in the Fight Against Chronic Lymphocytic Leukemia? Motley Fool
View ArticleGSK and Genmab Announce European Submission to Regulatory Authorities for...
GSK and Genmab Announce European Submission to Regulatory Authorities for Arzerra(R) (Ofatumumab) as 1st Line Treatment of Chronic Lymphocytic Leukemia (CLL) Yahoo/Globe Newswire
View ArticleGSK/Genmab file Arzerra for first-line CLL
GSK/Genmab file Arzerra for first-line CLL Pharma Times, UK
View Article
More Pages to Explore .....
